Mark Field serves as the Senior Vice President and Chief Technology Officer at Insulet Corporation, a leading medical device company focused on developing innovative insulin delivery systems for people with diabetes. In his role, Field is responsible for overseeing the company's technology strategy and leading the development of new products and technologies that enhance the lives of Insulet's customers. His expertise in medical device development and his strategic vision have been instrumental in driving the company's growth and innovation. Prior to joining Insulet, Field held various leadership positions in the medical device industry, where he gained extensive experience in product development, regulatory affairs, and quality assurance. He has a proven track record of successfully bringing complex medical devices to market, ensuring they meet the highest standards of safety and efficacy. Field's background in engineering and his passion for improving patient outcomes have made him a valuable asset to Insulet and the diabetes community. Under Field's leadership, Insulet has continued to expand its portfolio of innovative insulin delivery solutions, including the development of the Omnipod® system, a tubeless, wearable insulin pump that offers users greater freedom and flexibility in managing their diabetes. Field's commitment to advancing technology and improving patient care has been recognized by his peers and the industry, solidifying his reputation as a thought leader in the field of medical device development. As Insulet continues to grow and innovate, Field's role as CTO will be crucial in shaping the future of diabetes management and improving the lives of millions of people worldwide.